In conclusion, our results demonstrate that low dose gemcitabine treatment can cause the changes of protein kinases, phosphatases and the corresponding signaling pathways, which may play important roles to induce stem cell characteristics in pancreatic cancer cells. This evidence concerns the gene WEE1 and pancreatic neoplasm.